clinical trial · NCT05706753
A Study of Milvexian in Healthy Adult Females
Janssen Pharmaceutica N.V., Belgium·phase1·completed·n = 20
Healthy FemaleMilvexianMidazolamEthinylestradiolDrospirenone
brief summary
The purpose of this study is to measure the effect of milvexian given for approximately 2 weeks on (a) how the liver metabolizes other drugs (in this case one called midazolam), and (b) the pharmacokinetics (the way the body absorbs, distributes, and gets rid of a drug) of an oral contraceptive pill in healthy adult females.
started
Jan 25, 2023
primary completion
Jul 20, 2023
completion
Jul 20, 2023
last updated
Mar 30, 2025
official title
An Open-label, Non-randomized Study to Investigate the Effects of Twice-Daily Milvexian Administration on the Pharmacokinetics of Single Doses of Midazolam, Ethinylestradiol and Drospirenone in Healthy Adult Females
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol